Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, Kleinschnitz C, Rauer S, Kuhle J, Stangel M, Weber F, Uhr M, Linnebank M, Wildemann B, Jarius S, Guger M, Ayzenberg I, Chan A, Zettl U, Wiendl H, Pilz G, Hitzl W, Weber JR, Kraus J.
Harrer A, et al. Among authors: kraus j.
Mult Scler. 2013 Aug;19(9):1209-12. doi: 10.1177/1352458512463483. Epub 2012 Oct 23.
Mult Scler. 2013.
PMID: 23093485